These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 22724878)

  • 41. [Clinical and histological features of non-alcoholic fatty liver disease].
    Shi JP; Xun YH; Hu CB; Zhang L; Liu H; Lou GQ; Fan JG
    Zhonghua Gan Zang Bing Za Zhi; 2009 Nov; 17(11):812-6. PubMed ID: 19958638
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Nonalcoholic fatty liver disease: different classifications concordance and relationship between degrees of morphological features and spectrum of the disease.
    Monteiro JM; Monteiro GM; Caroli-Bottino A; Pannain VL
    Anal Cell Pathol (Amst); 2014; 2014():526979. PubMed ID: 25763333
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cardiovascular disease and nonalcoholic fatty liver disease: does histologic severity matter?
    Domanski JP; Park SJ; Harrison SA
    J Clin Gastroenterol; 2012; 46(5):427-30. PubMed ID: 22469639
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Neutrophil to lymphocyte ratio: a new marker for predicting steatohepatitis and fibrosis in patients with nonalcoholic fatty liver disease.
    Alkhouri N; Morris-Stiff G; Campbell C; Lopez R; Tamimi TA; Yerian L; Zein NN; Feldstein AE
    Liver Int; 2012 Feb; 32(2):297-302. PubMed ID: 22097893
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hepatic stellate cell activation occurs in nonalcoholic steatohepatitis.
    Cortez-Pinto H; Baptista A; Camilo ME; de Moura MC
    Hepatogastroenterology; 2001; 48(37):87-90. PubMed ID: 11269008
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Leptin reverses nonalcoholic steatohepatitis in patients with severe lipodystrophy.
    Javor ED; Ghany MG; Cochran EK; Oral EA; DePaoli AM; Premkumar A; Kleiner DE; Gorden P
    Hepatology; 2005 Apr; 41(4):753-60. PubMed ID: 15791619
    [TBL] [Abstract][Full Text] [Related]  

  • 47. MRI findings in nonalcoholic steatohepatitis: correlation with histopathology and clinical staging.
    Elias J; Altun E; Zacks S; Armao DM; Woosley JT; Semelka RC
    Magn Reson Imaging; 2009 Sep; 27(7):976-87. PubMed ID: 19356874
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical trial: a nutritional supplement Viusid, in combination with diet and exercise, in patients with nonalcoholic fatty liver disease.
    Vilar Gomez E; Rodriguez De Miranda A; Gra Oramas B; Arus Soler E; Llanio Navarro R; Calzadilla Bertot L; Yasells Garcia A; Del Rosario Abreu Vazquez M
    Aliment Pharmacol Ther; 2009 Nov; 30(10):999-1009. PubMed ID: 19691668
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Histopathology of nonalcoholic fatty liver disease.
    Brunt EM; Tiniakos DG
    World J Gastroenterol; 2010 Nov; 16(42):5286-96. PubMed ID: 21072891
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of liver biopsy sample length and number of readings on sampling variability in nonalcoholic Fatty liver disease.
    Vuppalanchi R; Unalp A; Van Natta ML; Cummings OW; Sandrasegaran KE; Hameed T; Tonascia J; Chalasani N
    Clin Gastroenterol Hepatol; 2009 Apr; 7(4):481-6. PubMed ID: 19162235
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pathological study of 130 cases of nonalcoholic fatty liver disease based on NASH-CRN system.
    Zhou G; Zhao J; Ding X; Pan D; Sun Y; Yang J; Zhao Y
    Front Med China; 2007 Oct; 1(4):413-7. PubMed ID: 24573937
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Association between puberty and features of nonalcoholic fatty liver disease.
    Suzuki A; Abdelmalek MF; Schwimmer JB; Lavine JE; Scheimann AO; Unalp-Arida A; Yates KP; Sanyal AJ; Guy CD; Diehl AM;
    Clin Gastroenterol Hepatol; 2012 Jul; 10(7):786-94. PubMed ID: 22343513
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Genome-wide association study identifies variants associated with histologic features of nonalcoholic Fatty liver disease.
    Chalasani N; Guo X; Loomba R; Goodarzi MO; Haritunians T; Kwon S; Cui J; Taylor KD; Wilson L; Cummings OW; Chen YD; Rotter JI;
    Gastroenterology; 2010 Nov; 139(5):1567-76, 1576.e1-6. PubMed ID: 20708005
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Current histological classification of NAFLD: strength and limitations.
    Bedossa P
    Hepatol Int; 2013 Dec; 7 Suppl 2():765-70. PubMed ID: 26202292
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Reliability of histologic assessment for NAFLD and development of an expanded NAFLD activity score.
    Pai RK; Jairath V; Hogan M; Zou G; Adeyi OA; Anstee QM; Aqel BA; Behling C; Carey EJ; Clouston AD; Corey K; Feagan BG; Kleiner DE; Ma C; McFarlane SC; Noureddin M; Ratziu V; Valasek MA; Younossi ZM; Harrison SA; Loomba R
    Hepatology; 2022 Oct; 76(4):1150-1163. PubMed ID: 35332569
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Association Between Cytokines and Liver Histology in Children with Nonalcoholic Fatty Liver Disease.
    Perito ER; Ajmera V; Bass NM; Rosenthal P; Lavine JE; Schwimmer JB; Yates KP; Diehl AM; Molleston JP; Murray KF; Scheimann A; Gill R; Glidden D; Aouizerat B
    Hepatol Commun; 2017 Sep; 1(7):609-622. PubMed ID: 29130075
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Silent liver diseases in autopsies from forensic medicine of Tehran.
    Sotoudehmanesh R; Sotoudeh M; Ali-Asgari A; Abedi-Ardakani B; Tavangar SM; Khakinejad A; Sadeghi Z; Malekzadeh R
    Arch Iran Med; 2006 Oct; 9(4):324-8. PubMed ID: 17061603
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The Association Between IGF-1 Levels and the Histologic Severity of Nonalcoholic Fatty Liver Disease.
    Dichtel LE; Corey KE; Misdraji J; Bredella MA; Schorr M; Osganian SA; Young BJ; Sung JC; Miller KK
    Clin Transl Gastroenterol; 2017 Jan; 8(1):e217. PubMed ID: 28125073
    [TBL] [Abstract][Full Text] [Related]  

  • 59. In the non-cirrhotic stage of nonalcoholic steatohepatitis, angioarchitecture of portal veins and lobular architecture are maintained.
    Hano H; Takasaki S; Kobayashi H; Koyama T; Lu T; Nagatsuma K
    Virchows Arch; 2013 May; 462(5):533-40. PubMed ID: 23536281
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Fatty Liver Disease: A Practical Approach.
    Mostafa M; Abdelkader A; Evans JJ; Hagen CE; Hartley CP
    Arch Pathol Lab Med; 2020 Jan; 144(1):62-70. PubMed ID: 31603713
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.